H-EPLTSLTPRCNTAWNRLKL-OH

Ref. 3D-PP42967

Informations sur le produit

• Nom: H-EPLTSLTPRCNTAWNRLKL-OH
• Synonymes: NH2-Glu-Pro-Leu-Thr-Ser-Leu-Thr-Pro-Arg-Cys-Asn-Thr-Ala-Trp-Asn-Arg-Leu-Lys-Leu-OH

Description

Peptide H-EPLTSLTPRCNTAWNRLKL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-EPLTSLTPRCNTAWNRLKL-OH include the following: Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants T van Hall , EZ Wolpert, P van Veelen, S Laban - Nature medicine, 2006 - nature.comhttps://www.nature.com/articles/nm1381 The role of CD4+ helper T cells in immunity to acute friend retroviral infection S Nair - 2009 - core.ac.ukhttps://core.ac.uk/download/pdf/33799064.pdf Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity N van Montfoort , MG Camps, S Khan - Proceedings of the , 2009 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0900969106 Antigen Storage Compartments in Mature Dendritic Cells Facilitate Prolonged CTL Cross-Priming Capacity N van Montfoort , MG Camps, S Khan, DV Filippov - scholarlypublications https://scholarlypublications.universiteitleiden.nl/access/item%3A2924856/download Generation and expression of high affinity, tumor antigen-specific mouse and human T cell receptors to genetically modify CD8 (+) T cells for adoptive ML Dossett - 2006 - search.proquest.comhttps://search.proquest.com/openview/e15a6c0fb38ba9554ef38793b6bb4bcb/1?pq-origsite=gscholar&cbl=18750&diss=y Invasive margin tissue-resident macrophages of high CD163 expression impede responses to T cell-based immunotherapy MJ van Elsas, C Labrie, A Etzerodt - for Immunotherapy of , 2023 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016286/ Differential kinetics of antigen-specific CD4+ and CD8+ T cell responses in the regression of retrovirus-induced sarcomas K Schepers , M Toebes, G Sotthewes - The Journal of , 2002 - journals.aai.orghttps://journals.aai.org/jimmunol/article/169/6/3191/35338 Combination of photodynamic therapy and specific immunotherapy efficiently eradicates established tumors JW Kleinovink, PB van Driel, TJ Snoeks, N Prokopi - Clinical Cancer , 2016 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/22/6/1459/121249 Efficient induction of antitumor immunity by synthetic toll-like receptor ligand-peptide conjugates GG Zom , S Khan, CM Britten, V Sommandas - Cancer immunology , 2014 - AACRhttps://aacrjournals.org/cancerimmunolres/article-abstract/2/8/756/467661 Retroviral infection in vivo requires an immune escape virulence factor encrypted in the envelope protein of oncoretroviruses G Schlecht-Louf , M Renard - Proceedings of the , 2010 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0913122107 Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors F Ossendorp , E Mengede, M Camps, R Filius - The Journal of , 1998 - rupress.orghttps://rupress.org/jem/article-abstract/187/5/693/7454 Co-delivery of immunomodulators in biodegradable nanoparticles improves therapeutic efficacy of cancer vaccines CG Da Silva , MGM Camps, T Li, AB Chan - Biomaterials, 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0142961219305162

• Marque: Biosynth